Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 8.

Journal Article

Broeckelmann, Paul J., Mueller, Horst, Gillessen, Sarah, Yang, Xiaoqin, Koeppel, Larissa, Pilz, Veronika, Marinello, Patricia, Kaskel, Peter, Raut, Monika, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis. Leukemia, 36 (3). S. 772 - 781. LONDON: SPRINGERNATURE. ISSN 1476-5551

Gillessen, Sarah, Huettmann, Andreas, Vucinic, Vladan, Mueller, Horst, Pluetschow, Annette, Viardot, Andreas, Topp, Max S., Kobe, Carsten, Boell, Boris, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Sasse, Stephanie, Haverkamp, Heinz, Schmitz, Christine, Borchmann, Sven, Broeckelmann, Paul J., Heger, Jan-Michel, Fushs, Michael, Engert, Andreas, Borchmann, Peter and von Tresckow, Bastian (2022). Reinduction therapy with everolimus in combination with dexamethasone, high-dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD-R3i). Br. J. Haematol., 196 (3). S. 606 - 617. HOBOKEN: WILEY. ISSN 1365-2141

Gillessen, Sarah, Kobe, Carsten, Engert, Andreas and von Tresckow, Bastian (2020). PET positivity - the agony of choice: response assessment and interpretation of increased FDG uptake of residual mediastinal tissue after frontline therapy in Hodgkin lymphoma. Leuk. Lymphoma, 61 (2). S. 251 - 255. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Gillessen, Sarah, Pluetschow, Annette, Vucinic, Vladan ORCID: 0000-0002-8398-285X, Ostermann, Helmut, Kobe, Carsten, Broeckelmann, Paul J., Boell, Boris, Eichenauer, Dennis A., Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Engert, Andreas and von Tresckow, Bastian (2022). JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO). Eur. J. Haematol., 109 (6). S. 728 - 736. HOBOKEN: WILEY. ISSN 1600-0609

Graef, Claus Moritz, Goedel, Philipp, Falderbaum, Philipp, Balke-Want, Hyatt, Simon, Florian ORCID: 0000-0002-2700-3717, Sieg, Noelle, Naendrup, Jan-Hendrik, Neumann, Marie Anne-Catherine ORCID: 0000-0002-2396-6110, Gillessen, Sarah, Broeckelmann, Paul J., Eichenauer, Dennis A., Borchmann, Peter, von Tresckow, Bastian and Heger, Jan-Michel ORCID: 0000-0001-9463-8504 (2022). Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma. Eur. J. Haematol., 108 (5). S. 403 - 413. HOBOKEN: WILEY. ISSN 1600-0609

Jacob, Anne Sophie, Kaul, Helen, Fuchs, Michael, Gillessen, Sarah, Kreissl, Stefanie, Pluetschow, Annette, Momotow, Jesko, Schaub, Valdete, Huettmann, Andreas, Haenel, Mathias, Zimmermann, Andreas, Dierlamm, Judith, Meissner, Julia, Mathas, Stephan, Martin, Sonja, Engert, Andreas, Hallek, Michael ORCID: 0000-0002-7425-4455, Borchmann, Peter and Lehmann, Clara (2022). Impact of the first COVID-19 lockdown in Germany on the rate of acute infections during intensive chemotherapy for Hodgkin lymphoma. Infection, 50 (4). S. 925 - 933. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-0973

Kusch, Mona, Gillessen, Sarah, Saliger, Jochen, Karbe, Hans, Binder, Ellen, Fink, Gereon R. ORCID: 0000-0002-8230-1856, Vossel, Simone ORCID: 0000-0002-6351-8849 and Weiss, Peter H. ORCID: 0000-0002-5230-9080 (2018). Reduced Awareness for Apraxic Deficits in Left Hemisphere Stroke. Neuropsychology, 32 (4). S. 509 - 516. WASHINGTON: AMER PSYCHOLOGICAL ASSOC. ISSN 1931-1559

Sieg, Noelle, Naendrup, Jan-Hendrik, Goedel, Philipp, Balke-Want, Hyatt, Simon, Florian, Deckert, Martina, Gillessen, Sarah, Kreissl, Stefanie, Broeckelmann, Paul J., Borchmann, Peter, von Tresckow, Bastian and Heger, Jan-Michel (2021). Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma: Feasibility of MTX-based regimens in clinical routine. Eur. J. Haematol., 107 (2). S. 202 - 211. HOBOKEN: WILEY. ISSN 1600-0609

This list was generated on Fri Mar 29 09:52:43 2024 CET.